Google+

eNose Predicts Immunotherapy Treatment Effectiveness

It's claimed the device achieves 85 percent accuracy in predicting which lung cancer patients will, or will not, respond to new immunotherapy treatments
It’s claimed the device achieves 85 percent accuracy in predicting which lung cancer patients will, or will not, respond to new immunotherapy treatments
Amsterdam University Medical Centers

An impressive new study is suggesting a simple breath analysis can accurately predict whether lung cancer patients will positively respond to novel immunotherapy treatments. Unlike current methods, which involve studying tissue samples, the new “eNose” device can offer diagnostic advice in less than 60 seconds. read more

Lung Cancer Advancements

A chance meeting may lead to a combination therapy that actually reduces side effect damage while...
A chance meeting may lead to a combination therapy that actually reduces side effect damage while improving effectiveness of chemotherapy in the treatment of lung cancer(Credit: muratart/Depositphotos)

Cancer treatment is often a case of robbing Peter to pay Paul. You may well have some success with chemotherapy, but subsequent damage to otherwise healthy organs and tissue is a trade-off that clinicians and patients have had to juggle with for decades. But, thanks to a chance meeting at the Hudson Institute in Melbourne, lung cancer patients could be looking at more effective chemo with fewer side effects. read more